From the Anguish of the Stem Cell Controversy
Theresa “Tracy” Deisher may be best known for her recent contributions to the embryonic stem cell funding halt Read more…
Theresa “Tracy” Deisher may be best known for her recent contributions to the embryonic stem cell funding halt Read more…
Roth Capital initiated coverage (10/5/10) of ASTM with a BUY ranking with a target price of $3.50. Read more…
Geron/GE Healthcare has launched (10/5/10) the co-developed human cellular assay product human cardiomyocytes (heart muscle cells) Read more…
ISCO.OB has agreed on financial and structural terms for establishment of an Indian affiliate of ISCO India. Read more…
Preclinical data was published 10/5/10 on research performed showing adipose (fat)-derived stem and regenerative cells (ADRCs), either fresh or banked, demonstrated statistically significant improvements Read more…
The House of Representatives, 10/4/10, passed the reauthorization of the Stem Cell Therapeutic and Research Act (HR 6081). The vote extends the provisions of the bill, Read more…
Australian scientists have have developed a super-thin and springy substance that mimics conditions inside the human body; that can promote the growth of haemopoietic stem cells (HSCs) on a lab plate. Read more…
A pair of House lawmakers 9/30/10 introduced legislation designed to improve regenerative medical practices. Reps. Mike Castle (R-Del) and Diana DeGette (D-Colo) Read more…
A discovery about the behavior of cells in the intestine could help efforts to treat bowel cancer. Read more…
University of Michigan scientists have launched groundbreaking clinical trials that researchers hope will lead to a breakthrough in treatment for cancer with stem cells. Read more…